Srijit Seal | Visiting Researcher
Broad Institute of MIT and Harvard

Dr Srijit Seal is a computational scientist and researcher working at the intersection of artificial intelligence, chemoinformatics, and drug discovery. He currently serves as a visiting scientist at the Broad Institute of MIT and Harvard, Principal Advisor/Scientist at Human Chemical Company, and is a Visiting Researcher at Uppsala University. His pioneering work focuses on leveraging machine learning and image-based profiling, particularly the Cell Painting assay, to predict drug bioactivity, safety, and toxicity much earlier in the pharmaceutical development pipeline.